Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, DOSE, BAP-65

M. Gayaf (Izmir, Turkey), G. Karadeniz (Izmir, Turkey), F. Güldaval (Izmir, Turkey), G. Polat (Izmir, Turkey), M. Türk (Izmir, Turkey)

Source: Virtual Congress 2020 – Monitoring of patients with COPD
Session: Monitoring of patients with COPD
Session type: E-poster session
Number: 1048
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Gayaf (Izmir, Turkey), G. Karadeniz (Izmir, Turkey), F. Güldaval (Izmir, Turkey), G. Polat (Izmir, Turkey), M. Türk (Izmir, Turkey). Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, DOSE, BAP-65. 1048

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Commutity acquired pneumonia scores utility. PSI (FINE) vs BTSm (CURB)
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005


Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017

Comparison of PSI, A-DROP, CURB-65, CRB-65, and SOAR indices in hospitalized patients with community acquired pneumonia
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

A Comparison of three severity assessment scores: APACHI II SOFA and CURB 65 for predicting inpatient mortality in patients with acute exacerbation of COPD (AECOPD)
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015


Dyspnoea, obstruction, smoking and exacerbation (DOSE) index and mortality in COPD
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
Source: Eur Respir J 2008; 31: 349-355
Year: 2008



Prognostic value of the pneumonia severity index (PSI), CURB-65 for young and elderly patients
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Predicting in-hospital death in pneumonic COPD exacerbation via BAP-65, CURB-65 and machine learning
Source: ERJ Open Res, 8 (1) 00452-2021; 10.1183/23120541.00452-2021
Year: 2022



eCURB outperforms CURB-65 and A-DROP for predicting 30-day mortality in pneumonia
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


The index distance-saturation product like predicting of mortality in patients with COPD
Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment
Year: 2008


Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Mortality predictions of CURB-65, GPS and CALL scores in hospitalized patients with COVID-19
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021


A simplified BODE score to predict mortality in patients with COPD: the role of 4-min step test
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017

The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014


A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Evaluation of sequential organ failure assessment (SOFA) based models for predicting mortality in ICU patients
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Usefulness of CURB-65, PSI and MuLBSTA in predicting COVID-19 mortality
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021